VACCINATION UPTAKE IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL

被引：0
|
作者：
Pourhadi, H. [1 ]
Johnson, A. [1 ]
Foote, A. [1 ]
机构：
[1] Northern Hlth, Rheumatol, Epping, NSW, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
COVID; bDMARD; Vaccination/Immunization;
D O I：
10.1136/annrheumdis-2023-eular.5416
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1812-HPR
引用
收藏
页码：2139 / 2139
页数：1
相关论文
共 50 条
  • [1] VACCINATION UPTAKE IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL
    Pourhadi, Hedayat
    Johnson, Amy
    Foote, Andrew
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 51 - 52
  • [2] OUTCOMES OF HEPATITIS B AND TUBERCULOSIS SCREENING IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) FOR RHEUMATIC DISEASE AT A MELBOURNE PUBLIC HOSPITAL
    Pourhadi, H.
    Johnson, A.
    Foote, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2043 - 2044
  • [3] TREATMENT WITH BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL. RETENTION ON INITIAL BDMARD AT 36 MONTHS, AND PATTERNS OF CORTICOSTEROID USE BEFORE AND AFTER BDMARD COMMENCEMENT
    Pourhadi, Hedayat
    Foote, Andrew
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 38 - 39
  • [4] TIME TO INITIATION OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN THE FRENCH COHORT ESPOIR
    Joanna, Kedra
    Granger, Benjamin
    Emilie, Stephanie
    Gaujoux-Viala, Cecile
    Rat, Anne-Christine
    Combe, Bernard
    Fautrel, Bruno
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1147 - 1148
  • [5] Time to initiation of biologic disease-modifying antirheumatic drugs in the French cohort ESPOIR
    Kedra, Joanna
    Granger, Benjamin
    Emilie, Stephanie
    Gaujoux-Viala, Cecile
    Rat, Anne-Christine
    Combe, Bernard
    Fautrel, Bruno
    JOINT BONE SPINE, 2021, 88 (01)
  • [6] TREATMENT WITH BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (BDMARDS) FOR RHEUMATIC DISEASE AT A MELBOURNE PUBLIC HOSPITAL: BASELINE CHARACTERISTICS AND PRE-TREATMENT SCREENING
    Pourhadi, Hedayat
    Foote, Andrew
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 38 - 38
  • [7] BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS PRESCRIPTION OVER TIME IN A COHORT OF EARLY RHEUMATOID ARTHRITIS PATIENTS
    Fedele, A. L.
    Melpignano, F.
    Bruno, D.
    La Ferrara, R.
    D'agostino, M. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 603 - 603
  • [8] BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PSORIATIC ARTHRITIS: A REAL-WORLD COHORT OF 439 PATIENTS
    Letarouilly, J-G
    Salmon, J. -H.
    Coquerelle, P.
    Goeb, V.
    Guyot, M. -H.
    Houvenagel, E.
    Maury, F.
    Marguerie, L.
    Morel, G.
    Baudens, G.
    Solau-Gervais, E.
    Ramdane, N.
    Flipo, R. -M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 373 - 373
  • [9] Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases
    Fazaa, Alia
    Makhlouf, Yasmine
    Ben Ouhiba, Amad
    Miladi, Saoussen
    Sellami, Mariem
    Ouenniche, Kmar
    Souabni, Leila
    Kassab, Salma
    Chekili, Selma
    Zakraoui, Leith
    Ben Abdelghani, Kawther
    Laatar, Ahmed
    THERAPIE, 2021, 76 (05): : 467 - 474
  • [10] Disease-modifying antirheumatic drugs
    Lambert, David G.
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2012, 13 (03): : 128 - 130
12345